Demand for Wegovy and other GLP-1 drugs used to treat obesity and diabetes has skyrocketed, but a new report suggests that many people may not be sticking with their weight-loss treatment long enough.

2150033257

KRDO

Colorado Springs

El Paso County

Colorado

United States

Many people using GLP-1s for weight loss stop treatment too soon, research shows, and results are not one-size-fits-all

Ad Fontes Media

All Sides

Media Bias/Fact Check

Warner Bros. Discovery

Atlanta

Fulton County

Georgia

By Deidre McPhillips, CNN (CNN) — Demand for Wegovy and other GLP-1 drugs used to treat obesity and diabetes has skyrocketed, but a new report suggests that many people may not be sticking with their weight-loss treatment long enough. An analysis of health insurance claims released Tuesday found that most people using GLP-1 medications – about 58% – were on their treatment plan for less than 12 weeks, falling short of a key benchmark in the weig…

News-Press & Gazette Company

By Deidre McPhillips, CNN (CNN) — Demand for Wegovy and other GLP-1 drugs used to treat obesity and diabetes has skyrocketed, but a new report suggests that many people may not be sticking with their weight-loss treatment long enough. An analysis of health insurance claims released Tuesday found that most people using GLP-1 medications –

KMIZ

Many people using GLP-1s for weight loss stop treatment too soon, research shows, and results are not one-size-fits

(CNN) — Demand for Wegovy and other GLP-1 drugs used to treat obesity and diabetes has skyrocketed, but a new report suggests that many people may not be sticking with

Many people using GLP-1s for weight loss stop treatment too soon, research shows, and results are not one-size-fits-all

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics